Tympanostomy tubes are commonly placed to treat chronic otitis media with effusion and recurrent acute otitis media. In fact, tympanostomy tube placement is the most common ambulatory surgery ...
Please provide your email address to receive an email when new articles are posted on . Insertion of tympanostomy tubes is often recommended to improve middle ear ventilation in children with acute ...
The US Food and Drug Administration (FDA) has approved a new system for placement of tympanostomy tubes in children with otitis media that does not require general anesthesia. The Tubes Under Local ...
Otitis media is the most common medical problem in young children. The usual surgical treatment is myringotomy with insertion of tympanostomy tubes. There is debate about the usefulness of concomitant ...
May 6, 2009 (Baltimore, Maryland) — The insertion of tympanostomy tubes for recurrent ear infections has increased 35% in the past decade, and the number of visits for otitis media has decreased by ...
GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--Preceptis Medical, Inc., a pioneer in pediatric ENT innovation, today announced the publication of a health economic study assessing the financial impact of ...
SAN DIEGO, July 8, 2014 -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner ...
There is no long-term benefit to surgically placing tympanostomy tubes in a young child's ears to reduce the rate of recurrent ear infections during the ensuing two years compared with giving oral ...
MENLO PARK, Calif., Feb. 15, 2018 /PRNewswire/ -- Tusker Medical, Inc. today announced the enrollment of the first in-office patients in the OTTER Study, the pivotal clinical study for Tusker's TULA ...
GOLDEN VALLEY, Minn.--(BUSINESS WIRE)--Preceptis Medical, Inc. announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized the creation of a new add-on G code to identify and ...
LONDON, May 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the market introduction and first commercial procedure of its Tula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results